These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 6945007)

  • 1. Nuclear DNA content and the number of Barr bodies in premalignant and malignant lesions of the uterine cervix.
    Nishiya I; Ishizaki Y; Sasaki M
    Acta Cytol; 1981; 25(4):407-11. PubMed ID: 6945007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Biometric research in the diagnosis of precancerous states and endocervical cancer].
    Novik VI; Agroskin LS; Papaian GV; Solov'eva LV
    Arkh Patol; 1989; 51(12):45-50. PubMed ID: 2629663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of protein thiols in normal and pathological cells of the epithelium of the portio uteri.
    Bajardi F; Schauenstein E; Nöhammer G; Unger-Ullmann C
    Acta Cytol; 1977; 21(4):573-7. PubMed ID: 269611
    [No Abstract]   [Full Text] [Related]  

  • 4. [Nuclear DNA content and chromosomal counts of cultured cells derived from human cervix with normal and abnormal epithelia].
    Hayakawa O; Kusanagi T; Kudo R
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Feb; 37(2):229-36. PubMed ID: 3973446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desmosomes and gap junctions in precarcinomatous and carcinomatous conditions of squamous epithelia. An electron microscopic and morphometrical study.
    Kocher O; Amaudruz M; Schindler AM; Gabbiani G
    J Submicrosc Cytol; 1981 Apr; 13(2):267-81. PubMed ID: 7338968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromatin appearance in intermediate cells from patients with uterine cancer.
    Bibbo M; Bartels PH; Sychra JJ; Wied GL
    Acta Cytol; 1981; 25(1):23-8. PubMed ID: 6162305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Quantitative characteristics of the structural changes in the cell nuclei in pathological states of the cervix uteri].
    Zheleznov BI; Ezhova LS
    Akush Ginekol (Mosk); 1982 Apr; (4):51-5. PubMed ID: 7102972
    [No Abstract]   [Full Text] [Related]  

  • 8. [The changes in nuclear DNA amounts in the development and progression of uterine cervical cancer determined by cytofluorometry].
    Harada K
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 May; 38(5):759-68. PubMed ID: 3722955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of sex chromatin in exfoliated cervical cells under different physiologic and pathologic conditions.
    De M; Chowdhury JR
    Indian J Pathol Microbiol; 1984 Jul; 27(3):215-22. PubMed ID: 6530287
    [No Abstract]   [Full Text] [Related]  

  • 10. Precursors of cervical cancer: ultrastructural morphology.
    Stegner HE
    Curr Top Pathol; 1981; 70():171-193. PubMed ID: 7297132
    [No Abstract]   [Full Text] [Related]  

  • 11. Koilocytosis in dysplastic and reactive cervical squamous epithelium. An ultrastructural study.
    Okagaki T; Clark BA; Brooker DC; Williams PP
    Acta Cytol; 1978; 22(2):95-8. PubMed ID: 276240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cytofotometrically Determined DNA-pattern of premalignant cases of dysplasia of the cervix uteri. Contribution to the problem of morphologic definition and clinical sigificance of these lesions (author's transl)].
    Sachs H; Schittko G
    Arch Gynakol; 1975; 218(2):95-112. PubMed ID: 50831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Premalignant lesions of the cervix in women of Cali, Colombia.
    Duque E; Cuello C; Aristizábal N; Haenszel W; Botero S; Correa P
    J Natl Cancer Inst; 1979 Oct; 63(4):953-63. PubMed ID: 480388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferative activity in dysplasia, carcinoma in situ and microinvasive carcinoma of the uterine cervix.
    Tanaka T
    Pathol Res Pract; 1986 Oct; 181(5):531-9. PubMed ID: 3786246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cytofluorimetric research on the epithelium of the cervix uteri in malignancy].
    Ganina KP; Nosa PP; Boroda AN; Klevetenko MP
    Tsitol Genet; 1993; 27(2):30-7. PubMed ID: 8212323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric classification of biopsy specimens from cervical intraepithelial neoplasia.
    Jakobsen A; Kristensen PB; Poulsen HK
    Cytometry; 1983 Sep; 4(2):166-9. PubMed ID: 6628138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [DNA content in dysplasias and early invasive forms of cervical cancer].
    Chebanu FA; Kushch AA; Zelenin AV
    Vopr Onkol; 1977; 23(12):64-6. PubMed ID: 602080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ultrastructural characteristics of cervical dysplasia and carcinoma in situ].
    Iakovleva IA; Chernyĭ AP
    Arkh Patol; 1982; 44(6):20-6. PubMed ID: 7125928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevalence of premalignant lesions of the cervix uteri. Comparative study between a female population using contraceptives].
    Arizaga Cruz JM; García González J; Garrido Cuevas M; Ortíz Díaz C
    Ginecol Obstet Mex; 1979 Jul; 46(273):37-44. PubMed ID: 527851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two types of cells in the normal and atypical squamous epithelium of the cervix. II. Light microscopic study in human subjects.
    Rubio CA
    Acta Cytol; 1982; 26(2):121-5. PubMed ID: 6952710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.